Vitanova Biomedical, Inc.

KERRVILLE, TX · CIK 0002125206 · Biotech · Private

Light-activated nanoparticles that target and kill cancer cells via induced intracellular acidosis

vitanovabiomedical.com →
Grants
$225K
1 award
Sector median: 1
Raised
$8.0M
1 Form D · May 2026
5 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: An energy-based therapeutic to treat prostate cancer$225,000
Private capital raisedForm D · SEC$8,000,000
Federal grant · SBIR/STTRForm D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2946Atropos Therapeutics, Inc.——
2947MALARVX, INC.—$235K
2948ENEPRET, INC.——
2949Vitanova Biomedical, Inc.—$8.0M
2950OnCusp Therapeutics——
2951COVALABIO INC.——
2952PLUMB PHARMACEUTICALS, INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Matthew GdovinExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.